Exploring neuropharmacokinetics: mechanisms, models, and clinical implications
Seon-Jae Ahn1,2
1Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Encephalitis (Seoul, Korea)
|April 7, 2025
Summary
Neuropharmacokinetics explores how drugs move in the central nervous system (CNS), focusing on overcoming the blood-brain barrier. Recent advances in drug delivery and imaging improve CNS drug efficacy for neurological disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Drug Delivery
Background:
- Neuropharmacokinetics studies drug behavior in the central nervous system (CNS).
- The blood-brain barrier (BBB) presents a significant challenge for CNS drug delivery.
- Understanding drug pharmacokinetics in the CNS is crucial for treating neurological and psychiatric disorders.
Purpose of the Study:
- To review recent advancements in neuropharmacokinetics.
- To highlight novel drug delivery strategies for enhanced brain penetration.
- To discuss the role of advanced imaging in assessing CNS drug action.
Main Methods:
- Review of nanoparticle-based drug delivery systems.
- Analysis of receptor-mediated transcytosis and efflux transporter inhibition strategies.
- Examination of advanced imaging techniques like PET, fMRI, and MRI.
Main Results:
- Novel drug delivery methods show promise in improving drug penetration across the BBB.
- Advanced imaging techniques provide valuable data on drug distribution and target engagement in the CNS.
- These innovations offer new avenues for therapeutic interventions.
Conclusions:
- Significant progress has been made in neuropharmacokinetics, particularly in overcoming the BBB.
- Enhanced drug delivery and imaging are critical for developing effective CNS therapies.
- These advancements hold potential for improved treatment of neurological and psychiatric conditions.
More Related Videos
Related Concept Videos
01:20Pharmacokinetic Models: Overview
509
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
509
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
22
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
22
01:26Pharmacokinetic Models: Comparison and Selection Criterion
26
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
26
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
61
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
61
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
20
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
20
01:21Mechanistic Models: Overview of Compartment Models
49
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
49